Science & Enterprise subscription

Follow us on Twitter

  • Results from a clinical trial show a combination of two synthetic antibodies reduces deaths in hospitalized Covid-1… https://t.co/AtztCHfZLl
    about 11 hours ago
  • New post on Science and Enterprise: Antibodies Help Some Hospitalized Covid-19 Patients https://t.co/lJhns0fZzJ #Science #Business
    about 11 hours ago
  • https://t.co/BUeUy0ajO3 ... Crocodile on the Tarcoles River in Costa Rica, for #NaturePhotographyDay ... February 2020.
    about 1 day ago
  • https://t.co/mtU98giel5 Oystercatcher for #NaturePhotographyDay ... Cape May, New Jersey. June 2019.
    about 1 day ago
  • Two biotechnology companies are designing therapies to deliver edited genes to treat Friedreich’s ataxia and amyotr… https://t.co/7tbDhyf5lv
    about 1 day ago

Please share Science & Enterprise

Biotechs Partner on Crispr Therapies for Neuro Disorders

Adeno-associated virus

Two biotechnology companies are designing therapies to deliver edited genes to treat Friedreich’s ataxia and amyotrophic lateral sclerosis, or ALS. . . . → Read More: Biotechs Partner on Crispr Therapies for Neuro Disorders

Diverse Genomic Variation Analytics Panel Created

Population genetics

A synthetic biology company and genetics research service are providing analytics on population genomic variations they say are more racially and ethnically diverse. . . . → Read More: Diverse Genomic Variation Analytics Panel Created

DNA Data Search, Retrieval Medium Designed

Digital DNA

A bioengineering team created a practical technique for using DNA as a medium to store and retrieve vast and rapidly growing volumes of data. . . . → Read More: DNA Data Search, Retrieval Medium Designed

Genetic Link Found for Covid-19 Loss of Smell

Saliva sample kit

A genetic analysis identifies a single genetic variation associated with loss of smell and taste, an early symptom in many people with Covid-19 infections. . . . → Read More: Genetic Link Found for Covid-19 Loss of Smell

Precision Cancer Meds Company Raises $43M in Early Funds

Network pointer

A company combining computational genetic analysis and precision medicine discovery for cancer therapies is raising $43 million in its first venture round. . . . → Read More: Precision Cancer Meds Company Raises $43M in Early Funds

Moderna Expands Vaccine Research, Mfring in Asia

Syringe and three vials

Moderna Inc. and South Korea signed agreements Saturday on joint research and manufacturing opportunities for vaccines against viruses in Korea. . . . → Read More: Moderna Expands Vaccine Research, Mfring in Asia

Crispr Treatment Leads to Durable Cholesterol Reduction

Crispr graphic

A developer of gene editing for inherited heart disease reports lab monkeys given its therapy experience lower cholesterol levels for at least eight months. . . . → Read More: Crispr Treatment Leads to Durable Cholesterol Reduction

Gene Therapy Company Starts-Up, Gains $200M

Adeno-associated virus

A new company is underway commercializing research on gene therapies for inherited diseases, staked to an initial investment of $200 million. . . . → Read More: Gene Therapy Company Starts-Up, Gains $200M

New Biotech Creating Precision Cancer Therapies

DNA analysis graphic

A biotechnology company began work in public to develop new treatments that target proteins responsible for gene expression, beginning with cancer. . . . → Read More: New Biotech Creating Precision Cancer Therapies

Synthetic Bio Company Goes Public in $2.5B Merger

Investment graphic

A company developing synthetic biology and engineering tools for biotechnology is becoming a public company through a special-purpose acquisition. . . . → Read More: Synthetic Bio Company Goes Public in $2.5B Merger